Monsanto Deal Below $140/Share - Reasonable For Bayer, Says Deutsche Bank

Bayer's offer for Monsanto has not been taken well by investors. Belief is that the financing structure as well as differences in opinion between management and investors have all contributed to the stock dropping 15% in the past two weeks.